My watch list

Rufinamide


Rufinamide
Systematic (IUPAC) name
1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide
Identifiers
CAS number	106308-44-5
ATC code	N03AF03
PubChem	129228
Chemical data
Formula	C₁₀H₈F₂N₄O
Mol. mass	238.194
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Rufinamide is an anticonvulsant medication.

Additional recommended knowledge

What is the Correct Way to Check Repeatability in Balances?

Used in combination with other medication and therapy to treat Lennox-Gastaut syndrome and various other seizure disorders, Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai.

References

Drugs.com - Rufinamide
Epilepsy.com - Rufinamide

v • d • e Anticonvulsants (N03)
Barbiturates	Barbexaclone, Metharbital, Methylphenobarbital, Pentobarbital, Phenobarbital, Primidone
Hydantoins	Ethotoin, Fosphenytoin, Mephenytoin, Phenytoin
Oxazolidinediones	Ethadione, Paramethadione, Trimethadione
Succinimides	Ethosuximide, Mesuximide, Phensuximide
Benzodiazepines	Clobazam, Clonazepam, Clorazepate, Diazepam, Lorazepam, Midazolam, Nitrazepam, Temazepam
Carboxamides	Carbamazepine, Oxcarbazepine, Rufinamide
Fatty acid derivatives	Valpromide, Valnoctamide
Carboxylic acids	Valproic acid (Sodium valproate & Valproate semisodium), Tiagabine
Others	GABA analogs: Gabapentin, Pregabalin, Progabide, Vigabatrin -- Monosaccharides: Topiramate -- Aromatic allylic alcohols: Stiripentol -- Ureas: Phenacemide, Pheneturide -- Phenyltriazines: Lamotrigine Carbamates: Emylcamate, Felbamate, Meprobamate -- Pyrrolidines: Brivaracetam, Levetiracetam, Nefiracetam, Seletracetam Sulfa drugs: Acetazolamide, Ethoxzolamide, Sultiame, Zonisamide -- Propionates: Beclamide -- Aldehydes: Paraldehyde -- Bromides: Potassium bromide, Sodium bromide